| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | isonicotinohydroxamic acid | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.7 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.7 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
| mRNA | AZD0530 | FIMM | pan-cancer | AAC | -0.051 | 0.7 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.018 | 0.8 |
| mRNA | embelin | GDSC1000 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.8 |